InvestorsHub Logo
icon url

Ortiz26

02/03/17 8:42 AM

#45673 RE: FELLER #45671

Which amazes me how undervalued we are. We have the patents, one clinical trial underway and possibly a second trial approved soon for multiple myeloma.
AXIM market cap puts us around $5.